India's largest private cancer hospital network, with dozens of centres across South Asia and Africa and an early lead in CyberKnife, PET-CT and molecular diagnostics.
HealthCare Global Enterprises was founded by B.S. Ajaikumar in Bengaluru and grew into the largest specialist cancer chain in India, with a network of comprehensive cancer centres across India plus units in Kenya and elsewhere in Africa. HCG introduced several technologies early to India, including CyberKnife robotic radiosurgery, hospital-based cyclotrons and PET-CT, and its Triesta Sciences and Strand Life Sciences diagnostic arms provide next-generation sequencing, liquid biopsy and molecular pathology. The group runs a sizeable clinical trials business, a bone marrow transplant network and academic training, and publishes on outcomes of cancer care in Indian private practice.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-01.
Matched to Healthcare Global Enterprises, including child institutions. 46 works · 54 citations · 72% open access · 17% clinical trials · 4% reviews.
Shares PET/CT, SBRT / SABR (stereotactic radiotherapy), Head and neck squamous cell carcinoma, Non-small-cell lung cancer.
Shares PET/CT, Cervical cancer, Head and neck squamous cell carcinoma, Non-small-cell lung cancer.
Shares PET/CT, Liquid biopsy (ctDNA).
Shares PET/CT, Head and neck squamous cell carcinoma, HR-positive / HER2-negative breast cancer.
Shares PET/CT, HR-positive / HER2-negative breast cancer, Non-small-cell lung cancer.
Shares PET/CT, SBRT / SABR (stereotactic radiotherapy), Non-small-cell lung cancer.
Shares PET/CT, SBRT / SABR (stereotactic radiotherapy), HR-positive / HER2-negative breast cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/